REGN vs SKT · P/E 14, rev $4.29B vs P/E 37, rev $306.8M
Regeneron Pharmaceuticals Inc (REGN) versus Tanger Factory Outlet Centers Inc (SKT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tanger Factory Outlet Centers Inc (SKT) is a reit - retail company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SKT revenue for 2026-06-30 was $306.8M. Net income was $61.5M. SKT currently screens at market cap $3.59B and trailing P/E 37.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SKT currently screens at market cap $3.59B and trailing P/E 37.3.
Not investment advice. Open the REGN and SKT stock pages for the full models.
Not investment advice.